MMP2 and plasma cell myeloma: While BMMPIs did not impact multiple myeloma cell line survival significantly in vitro, we expected that they may be effective in the context of the in vivo bone microenvironment given the combined presence of MMP-2 in the multiple myeloma and host compartments.